Last reviewed · How we verify
NCT04483817
Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.
NA trial testing Transcutaneous tibial nerve stimulation in Overactive Bladder Syndrome in 104 participants. Status unknown.
1 February 2023
Quick facts
| Lead sponsor | Fisiocore LC,SL |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 104 |
| Start date | 17 July 2019 |
| Primary completion | 1 February 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Transcutaneous tibial nerve stimulation
- Percutaneous tibial nerve stimulation
Conditions studied
- Overactive Bladder Syndrome — all drugs for Overactive Bladder Syndrome →
Sponsor
Fisiocore LC,SL
Who can join
18 and older, any sex, with Overactive Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this study, is compare the effectiveness of transcutaneous posterior tibial nerve stimulation versus percutaneous posterior nerve stimulation in patients with overactive bladder.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04483817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcutaneous tibial nerve stimulation
Trials testing the same drug.
- NCT05977634 — Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder · NA · active not recruiting
- NCT04896814 — Transcutaneous Tibial Nerve Stimulation as Treatment for Women With Primary Dysmenorrhea · NA · completed
- NCT04528784 — Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis · NA · completed
Other recruiting trials for Overactive Bladder Syndrome
Currently open trials in the same condition.
- NCT05895045 — Yoga for Treatment of Overactive Bladder in Pediatric Patients · NA · recruiting
- NCT07081412 — Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation · NA · recruiting
- NCT07184307 — Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial · NA · recruiting
- NCT06546189 — Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial · NA · recruiting
- NCT06351683 — Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04483817 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fisiocore LC,SL
- Last refreshed: 9 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04483817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing